Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06673498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 5, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To assess the efficacy and safety of lusutrombopag combined with recombinant human thrombopoietin for the treatment of thrombocytopenia in patients with chronic liver disease destined to undergo elective invasive surgery.
Trial Details
NCT Number NCT06673498
Lead Sponsor Anhui Provincial Hospital
Conditions
(from sponsor)		 Thrombocytopenia
Related terms Thrombocytopenia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov